Navigation Links
SPRI Clinical Trials Now Enrolling Patients for Study of New Treatment for Depression
Date:10/15/2007

Patient Recruitment Starting Now -- For More Information, Call 888-345-7774

or Visit Our Website at http://www.spristudy.com

NEW YORK, Oct. 15 /PRNewswire/ -- SPRI Clinical Trials announced today that it is now screening patients for enrollment in the parAGOn Clinical Trial Program, which will start with two Phase III studies to evaluate the efficacy, safety and tolerability of agomelatine, a novel, investigational, once-daily medication for the treatment of Major Depressive Disorder (MDD). The 8-week, randomized, placebo-controlled studies are sponsored by Novartis Pharmaceuticals Corporation, and each of the two Phase III studies will include 490 patients from approximately 50 centers.

This investigational new drug targets both melatonin receptors and serotonin (5-HT2c) receptors.

The parAGOn Clinical Trial Program is open to patients between the ages of 18 and 70 who are experiencing MDD and meet other eligibility criteria. Eligible patients will be equally randomized to receive either treatment with agomelatine 25 mg, agomelatine 50 mg or placebo once daily for 8 weeks. Patients who complete the eight-week double-blind treatment phase may also participate in a 52-week open-label extension of the study.

MDD is the most common mood disorder, affecting approximately 15 million American adults, according to the National Alliance on Mental Illness. Common symptoms include: depressed mood, loss of interest in daily activities, poor concentration, weight loss (or gain), decrease of appetite, sleep disturbance, feelings of worthlessness and /or of guilt, and suicidal ideation. Episodes of depression may be chronic and recurrent, according to the National Institute of Mental Health.

Contact Dr. Nick Vatakis at 888-345-7774 for more information about the ParAGOn Clinical Trial Program.


'/>"/>
SOURCE SPRI Clinical Trials
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013   NextDocs announced today that ... research organization, at DIA 2013 , the Drug ... present case studies that explore best practices for making ... trial master file (eTMF) systems. Sharon ... alongside Krystyna Kowalczyk , executive vice president of ...
(Date:6/19/2013)... , June 19, 2013  Caradigm today ... a solution designed to help healthcare organizations ... data while supporting their compliance with data ... represents a milestone in the delivery of ... capabilities for health systems. ...
(Date:6/19/2013)... , June 19, 2013   Voices Against ... finding a cure for brain cancer, today announced that ... grant to support the clinical investigation of Toca 511 ... high grade glioma brain cancer (Grade 3 or Grade ... novel treatments for advanced cancer, with an initial focus ...
Breaking Medicine Technology:NextDocs and Novella to Present on eTMF at DIA 2013 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3
... MINNETONKA, Minn., Aug. 25 MedNet Solutions, a ... clinical study management systems, is pleased to announce ... Inc. 5000 list for the fourth year in ... compiled annually by Inc. magazine, recognizes ...
... VIEJO, Calif., Aug. 25 Ambry Genetics, a global ... acquired the Illumina HiSeq 2000 Next Generation Sequencing System ... BeadXpress Genotyping System. Ambry Genetics has been an early ... extensive experience as a Certified Service Provider. A team ...
Cached Medicine Technology:MedNet Solutions Named to the Inc. 5000 List of Fastest Growing Companies for the Fourth Consecutive Year 2Ambry Genetics Announces the Addition of Illumina HiSeq 2000 and First 510(K) Approved BeadXpress® to Its Sequencing and Genotyping Capabilities 2
(Date:6/19/2013)... Texas (PRWEB) June 19, 2013 ... today announced its intent to purchase privately ... Florida, a leader in wheelchair accessible vehicle sales, ... of Auto Mobility Sales, Inc compliments and expands ... wheelchair accessible mobility dealers . The acquisition ...
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Kleritec, ... its website located at http://www.kleritec.com . In the ... creative, pre-selected, art and activities packages for pre-school and ... products as a method to aid teachers across the ... and engaged in learning. , Included in the art ...
(Date:6/19/2013)... Citi Bike has come to New York City in ... to know for sure how many patients will choose to take ... the option. In fact, he’s happy about anything that might ... it more convenient for them to visit his office at 133 ... Alternative Medicine at Back and Body Medical and an experienced ...
(Date:6/19/2013)... - In a major international study led by researchers ... the targeted therapy ibrutinib continues to show remarkable promise ... lymphoma (MCL). , The most recent interim findings of ... the New England Journal of Medicine . Previous ... 54th American Society of Hematology Annual Meeting and Exposition. ...
(Date:6/19/2013)... Children had half as many emergency department visits ... on five or more days a week, according to ... Children,s Hospital and Johns Hopkins University. , The new ... Journal of Pediatrics and will be presented at ... an important step in understanding where primary care practices ...
Breaking Medicine News(10 mins):Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:Kleritec Announces Addition of Educational Products. 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Extended primary care office hours might help keep kids out of the emergency department 2
... in heart attack or mortality rates , , SUNDAY, Nov. 4 ... to date, Harvard researchers report that they have found drug-eluting ... than bare metal stents do. , "There has been a ... investigator Dr. Laura Mauri, an assistant professor of medicine at ...
... ... Heart Association,s Scientific Sessions 2007 ... 4 , WHO: Dr. Amir Lerman, Professor of Medicine, Mayo Clinic, Rochester, MN ... Sweden Mr. Israel Schreiber, President ...
... North Carolina team of doctors, nurses, hospitals and emergency ... to provide faster, more effective treatment for heart attack ... fancy new equipment. But it does require competitors to ... move treatment forward empowering emergency services personnel in ...
... props open closed aortas in older patients, research suggests ... high-risk heart patients with narrowed aortas who typically need ... option -- an implanted, balloon-expandable aortic valve. , The ... the problem valve and then inflated, experts said. In ...
... increase in their risk of heart attacks or other ... the largest-ever study of the issue, being presented at ... Scientific Exposition in San Francisco. , Although donors are ... (hypertension) during follow-up, it is unclear whether this represents ...
... Union Election, Note Hospital System Failing ... to Live Up to its Own ... elected officials and other healthcare activists joined hospital,workers from the St. ... Hospital on Saturday, where they called for the health,system,s leadership to ...
Cached Medicine News:Health News:Drug-Coated Stents No Riskier in Long Run Than Bare Metal Ones 2Health News:Drug-Coated Stents No Riskier in Long Run Than Bare Metal Ones 3Health News:How Early Can We Detect Cardiovascular Disease Less Expensively ... Even in Childhood? 2Health News:RACE: a statewide model of better, faster heart attack care 2Health News:RACE: a statewide model of better, faster heart attack care 3Health News:Balloon Valve May Be Alternative to Open-Heart Surgery 2Health News:Balloon Valve May Be Alternative to Open-Heart Surgery 3Health News:No increase in cardiovascular risk for living kidney donors 2Health News:Healthcare Workers, Community Activists Call for Fair Election Agreement at St. Joseph Health System 2
The Fujinon's R410 laparoscope is the first to bring a 410,000 pixel CCD to the end of the scope. Superior imaging and color replication, along with a unique lens washing capability make the R410 the...
The ACMI™ Operative Laparoscopy System is designed for single- and dual-incision CO2 laser procedures and is used with 45cm laparoscopic instruments....
The edge-to-edge clarity of the laparoscopes provides excellent image definition.Even small structures are easily recognized due to the optimal depth of focus. The outstanding optical quality provide...
Stryker bariatric laparoscopes set the standard in picture quality....
Medicine Products: